VISITS | Pre-Treatment (Screening, Waiting time, Baseline/Visit 1 Randomisation) | Treatment | Post-Treatment Follow-up | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
 | Phone Visit 2–3 | Visit 4 | Phone Visit 5–6 | Visit 7 | Phone Visit 8–12 | Last Visit, EOT | |||||
TIME |  | Week − 4 to Day − 1 | Day 0 | Month 1 & 2 | Month 3 | Month 4 & 5 | Month 6 | Month 7–11 | Month 12 | ||
Pre-Screening | X | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Waiting time | Â | X | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Randomisation | Â | Â | Â | X | Â | Â | Â | Â | Â | Â | Â |
Informed consent | Â | Â | X | Â | Â | Â | Â | Â | Â | Â | Â |
In-, exclusion criteria | Â | Â | X | Â | Â | Â | Â | Â | Â | Â | Â |
Demographic Data | Â | Â | X | Â | Â | Â | Â | Â | Â | Â | Â |
Handing out Study Book | Â | Â | Â | Â | X | Â | Â | Â | Â | Â | Â |
Fall prevention information | Â | Â | Â | Â | X | Â | Â | Â | Â | Â | Â |
Recommendation to visit primary care doctor | Â | Â | Â | Â | X | Â | Â | Â | Â | Â | Â |
Start treatment or control per participant | Â | Â | Â | Â | X | Â | Â | Â | Â | Â | Â |
Review fall diary | Â | Â | Â | Â | Â | X | X | X | X | X | X |
BBS | Â | Â | X | Â | Â | Â | X | Â | X | Â | X |
MoCA | Â | Â | X | Â | Â | Â | X | Â | X | Â | X |
IADL | Â | Â | X | Â | Â | Â | X | Â | X | Â | X |
Medications | Â | Â | X | Â | Â | Â | X | Â | X | Â | X |
Baseline Questions | Â | Â | X | Â | Â | Â | Â | Â | Â | Â | Â |
Short FES-I | Â | Â | X | Â | Â | Â | X | Â | X | Â | X |
GDS-15 | Â | Â | X | Â | Â | Â | X | Â | X | Â | X |
SF-12 | Â | Â | X | Â | Â | Â | X | Â | X | Â | X |
ICPH (only EYT and Tai Chi group) | Â | Â | Â | Â | Â | Â | X | Â | X | Â | Â |
FIMA | Â | Â | X | Â | Â | Â | X | Â | X | Â | X |
Safety; complications | Â | Â | Â | Â | Â | X | X | X | X | X | X |
Adherence, motivation, additional interventions | Â | Â | Â | Â | Â | Â | Â | Â | X | Â | Â |